Champions of Change: DME Advocates Driving Real Change

Published in Government Relations on October 31, 2025

Real change starts with real people. In this edition of Champions of Change, we’re spotlighting two DME advocates who aren’t just talking about problems—they’re taking action. David Griffin and Gary Rench are showing us what it means to stand up for patients, providers, and the future of our industry.

David Griffin Champions Patient Access in the Face of Competitive Bidding Threats 

David Griffin, of Diabetes Specialty Supply in San Antonio, has emerged as a passionate advocate for patients and providers alike in the fight against the inclusion of continuous glucose monitors (CGMs) and other diabetes supplies in the next round of the Medicare Competitive Bidding Program. 

David Griffin
Sen. Ted Cruz's staff member and David Griffin

Deeply concerned about the potentially devastating consequences this change could bring to an already flawed system, David has made it his mission to raise awareness and drive action. He has taken a proactive approach, engaging directly with legislators across multiple states to share firsthand insights into how competitive bidding could disrupt access to essential diabetes care products. 

David’s outreach is not just about policy—it’s about people. David, who is also a CGM user, emphasizes the real-world impact on patients who rely on CGMs and diabetes supplies to manage their health safely and effectively. By highlighting the risks of reduced access, limited supplier participation, and compromised care quality, David is helping lawmakers understand the urgency of the issue. 

His efforts reflect the kind of grassroots advocacy that can make a difference. Through persistent dialogue, education, and collaboration, David is working to ensure that diabetic patients are not left behind in future policy decisions. 

Gary Rench Pushes Back Against Regulatory Overreach in Idaho 

Gary RenchFor the past few years, the National Supplier Clearinghouse (NSC) has been enforcing a position paper that appeared on the Idaho Board of Pharmacy’s website. The context of the paper stated that it was the board’s opinion that a licensed respiratory care practitioner or other qualified licensed healthcare provider must perform the setup and training of oxygen equipment and supplies. 

This interpretation created a major challenge for oxygen suppliers, as NSC began enforcing this opinion as if it were law during supplier enrollment and recertification reviews. As a result, many suppliers were forced to contract with licensed staff solely to meet this perceived requirement. 

Despite strong opposition from suppliers across the state, the NSC’s stance remained unchanged—until recently. 

One Big Sky AMES member, Gary Rench of Sandcreek Medical, refused to give up. Gary remained persistent and worked directly with the Idaho BOP, Idaho Medicaid, and the Idaho Board of Medicine to address the issue. During a recent online meeting, he presented the real-world impact this position paper was having on oxygen suppliers, noting that it could jeopardize his Medicare re-enrollment if not corrected. 

Following that meeting, Gary reached out to the Bureau Chief of the Board of Medicine for an update. She informed him that the board had updated their policy, and it would be posted later that same day. Gary thanked her for the opportunity to speak, and her response was, “It’s nice to have interaction with the regulated community and for the Board and staff to see how their actions impact the real world.” 

Thank you, David and Gary, for your unwavering commitment to strengthening and advancing the DME industry. 

If you're inspired to get more involved and help drive meaningful change, feel free to reach out at emily.kettman@vgm.com for assistance. 

From Our Experts

New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform thumbnail New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform The Medicare competitive bidding program for durable medical equipment (DME) was designed to reduce costs—but it's failing patients and providers. A new issue brief from Pacific Research Institute and economist Wayne Winegarden highlights what changes are urgently needed. Join HME Industry Letter on CB Program to CMS Administrator Oz thumbnail Join HME Industry Letter on CB Program to CMS Administrator Oz HME suppliers, manufacturers, and distributors are invited to add their company's name to a letter to CMS Administrator Dr. Mehmet Oz regarding the Administration's DMEPOS/Home Health Proposed Rule that includes provisions for a new competitive bidding round. The letter specifically asks CMS to withdraw or delay the DMEPOS provisions in the Proposed Rule and re-engage with industry, patient, and clinical stakeholders to design an evidence-based, fraud-resistant, America-First framework. Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program thumbnail Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program Now is the time to raise our voices. With the formal announcement of the Competitive Bidding (CB) Program expected as early as the end of this month, we must act swiftly and decisively. Below are two key opportunities to engage with your U.S. Representative and encourage their support for a Congressional letter urging Centers for Medicare & Medicaid Services (CMS) to pause and reassess the CB Program. Legislative Momentum in the HME Industry: Key Updates & Action Items thumbnail Legislative Momentum in the HME Industry: Key Updates & Action Items The past few months have seen a surge of legislative activity in the home medical equipment sector, with several key developments shaping policy and advocacy efforts across the industry. From new bills introduced in Congress to formal comment submissions and stakeholder mobilization, these events reflect growing momentum around critical issues affecting providers and patients alike. This article offers a comprehensive recap of recent actions and outlines important next steps for those... VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports thumbnail VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports VGM has submitted formal comments to the U.S. Department of Commerce in response to its Section 232 National Security Investigation into the importation of personal protective equipment (PPE), medical consumables, and medical equipment and devices. Senate Backs DME Relief Act with Bipartisan Support thumbnail Senate Backs DME Relief Act with Bipartisan Support In a significant development for the durable medical equipment (DME) industry and Medicare beneficiaries, the U.S. Senate has introduced S.2951, the companion legislation to H.R. 2005, known as the DMEPOS Relief Act of 2025. The Senate bill is being led by Senator James Lankford (R-OK) and has gained bipartisan support with Senator Maggie Hassan (D-NH) joining as a co-sponsor. Gov't Shutdown: What It Means for Providers thumbnail Gov't Shutdown: What It Means for Providers As expected, Democrats and Republican members of the Senate was unable to agree on terms in passing a continuing resolution (CR) ahead of the October 1st deadline, resulting in a government shutdown. But how did we get here? Oppose DMEPOS Bidding Expansion – Take Action Now thumbnail Oppose DMEPOS Bidding Expansion – Take Action Now A critical Congressional Sign-On Letter is now circulating in the House of Representatives, led by Reps. Neal Dunn (R-FL) and Greg Murphy (R-NC). This bipartisan letter calls on CMS to stop the proposed expansion of the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) Competitive Bidding Program to include ostomy and urological supplies.